A Randomized, Double-Blind, Placebo- and Active-Controlled, 4 Period Crossover Study To Evaluate the Effect of XP13512 on Cardiac Repolarization by Thorough Analysis of QTc Effect in Healthy Adult Subjects.

Trial Profile

A Randomized, Double-Blind, Placebo- and Active-Controlled, 4 Period Crossover Study To Evaluate the Effect of XP13512 on Cardiac Repolarization by Thorough Analysis of QTc Effect in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2012

At a glance

  • Drugs Gabapentin enacarbil (Primary) ; Moxifloxacin
  • Indications Diabetic neuropathies; Neuropathic pain; Restless legs syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top